| Date | Country | Title | Author |
|---|---|---|---|
| 26-Mar-2020 | SE | Sweden’s TLV issues negative opinion for J&J’s Imbruvica in mantle cell lymphoma | Eóin Ryan |
| 26-Mar-2020 | JP | Japan’s Chuikyo agrees to apply drug pricing rules to Novartis’s SMA gene therapy Zolgensma | Sophie Cairns |
| 26-Mar-2020 | KR | South Korea's Ministry of Health and Welfare reimburses AbbVie's chronic lymphocytic leukaemia treatment Venclexta from 1 April | Sophie Cairns |
| 26-Mar-2020 | DK | Danish Medicines Council evaluates Pfizer’s Xeljanz in ulcerative colitis | Eóin Ryan |
| 26-Mar-2020 | PT | Portugal rejects reimbursement of Cabometyx for first-line RCC | Ewa Oliveira da Silva |
| 26-Mar-2020 | RU | Russian Duma drafts amendment bill establishing penalties for overpricing of medicines in emergencies | Janet Beal |
| 24-Apr-2020 | RU | Russian senators push for expansion of centrally funded orphan disease list in 2021 | Janet Beal |
| 24-Mar-2021 | SE | Sweden’s NT Council recommends Roche’s Kadcyla in adjuvant breast cancer | Eóin Ryan |
| 24-Mar-2020 | US | FDA grants Gilead's COVID-19 antiviral candidate remdesivir orphan designation, as company halts emergency access due to demand | Margaret Labban |
| 24-Mar-2020 | PT | Portugal grants reimbursement to Vifor's Veltassa for hyperkalaemia | Ewa Oliveira da Silva |
| 24-Mar-2020 | GR | Greek reimbursement list update includes no new innovative medicines | Brendan Melck |
| 24-Mar-2020 | AbbVie becomes first company to drop patent rights for antiviral Kaletra being investigated for COVID-19 treatment | Margaret Labban | |
| 24-Mar-2020 | SE | Sweden’s NT Council recommends Alnylam’s Onpattro in hATTR after further price negotiations | Eóin Ryan |
| 24-Mar-2020 | IE | Ireland’s NCPE evaluates Ultragenyx’s Crysvita for X-linked hypophosphataemia | Eóin Ryan |
| 24-Mar-2020 | DE | Germany's G-BA announces exceptional decision-making changes in connection with COVID-19 outbreak | Brendan Melck |
| 17-Mar-2020 | DK | Novo Nordisk pauses clinical trials investigating concizumab in haemophilia | Eóin Ryan |
| 17-Mar-2020 | BG | Bulgaria’s NSCRLP introduces new mobile app to allow citizens to check prices amid reports of abuses | Brendan Melck |
| 17-Mar-2020 | DE | German GKV fund relaxes discount contract rules in light of COVID-19 virus pressures | Brendan Melck |
| 17-Mar-2020 | NG | Nigerian government targets 20 mil. people in temporary “five-day free healthcare” initiative | Sacha Baggili |
| 17-Mar-2020 | PT | Portugal issues therapeutic reference pricing update for Q2 | Ewa Oliveira da Silva |
